Nevro Corp. filed a notice of data breach with the Attorney General of Texas after discovering that information in the ...

Globus Medical has completed its acquisition of the US-based medical device company Nevro, broadening its market presence in ...

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

Nevro (NVRO) could be a solid choice for investors ... the stock -- for the current and following years is tracked by the system. The power of a changing earnings picture in determining near ...

Nevro Corp. engages in the development of medical ... It develops and commercializes the senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of ...

Shares of Nevro Corp. (NYSE:NVRO – Get Free Report) have earned a consensus rating of “Reduce” from the thirteen brokerages that are presently covering the firm, Marketbeat.com reports. Two investment ...

Nevro stock rises as it gains CE Mark for its HFX iQ SCS system, the first with AI-based personalized pain relief. 2024 revenue outlook raised amid positive earnings. Vandana Singh Airbnb Reports ...

The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to ...

April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition of Nevro ...

Nevro’s comprehensive HFX™ spinal cord stimulation (SCS) platform includes the Senza® SCS system and support services for the treatment of chronic pain of the trunk and limb and painful ...